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Maternal consumption of canola oil suppressed
mammary gland tumorigenesis in C3(1)
TAg mice offspring
Gabriela Ion, Juliana A Akinsete, W Elaine Hardman*
Abstract
Background: Maternal consumption of a diet high in omega 6 polyunsaturated fats (n-6 PUFA) has been shown
to increase risk whereas a diet high in omega 3 polyunsaturated fats (n-3 PUFA) from fish oil has been shown to
decrease risk for mammary gland cancer in female offspring of rats. The aim of this study was to determine
whether increasing n-3 PUFA and reducing n-6 PUFA by using canola oil instead of corn oil in the maternal diet
might reduce the risk for breast cancer in female offspring.
Methods: Female SV 129 mice were divided into two groups and placed on diets containing either 10% w/w corn
oil (which is 50% n-6 PUFA, control diet) or 10% w/w canola oil (which is 20% n-6 PUFA, 10% n-3 PUFA, test diet).
After two weeks on the diets the females were bred with homozygous C3(1) TAg transgenic mice. Mother mice
consumed the assigned diet throughout gestation and nursing of the offspring. After weaning, all female offspring
were maintained on the control diet.
Results: Compared to offspring of mothers fed the corn oil diet (CO/CO group), offspring of mothers fed the
canola oil diet (CA/CO group) had significantly fewer mammary glands with tumors throughout the experiment. At
130 days of age, the CA/CO group had significantly fewer tumors per mouse (multiplicity); the tumor incidence
(fraction of mice with any tumor) and the total tumor weight (per mouse that developed tumor) was less than
one half that of the CO/CO group. At 170 days of age, the total tumor weight per mouse was significantly less in
the CA/CO group and if a tumor developed the rate of tumor growth rate was half that of CO/CO group. These
results indicate that maternal consumption of canola oil was associated with delayed appearance of mammary
gland tumors and slowed growth of the tumors that developed.
Conclusions: Substituting canola oil for corn oil is an easy dietary change for people to make; such a change to
the maternal diet may decrease risk for breast cancer in the daughter.
Background
It has been shown that diets that contain high amounts
of omega 6 polyunsaturated fatty acids (PUFA) increase
the growth rates of cancers [1] whereas omega 3 PUFA
have been shown to reduce cancer growth rates [2] and
have been suggested as cancer preventive agents [3]. The
type of fat consumed by the mother during pregnancy
and nursing of the offspring has also been shown
to influence mammary gland cancer risk in the offspring.
A maternal diet that contained a high (versus low)
amount of omega 6 fatty acids increased the risk for
mammary gland cancer in the carcinogen treated off-
spring [4]. Compared to a corn oil diet, maternal con-
sumption of either an olive oil containing diet (high in
omega 9 fatty acid) [5] or of a diet containing long chain
omega 3 PUFA from fish oil [6] has been shown to
decrease carcinogen induced mammary gland cancer in
rat offspring. We have reported that the 18 carbon
omega 3 PUFA found in canola oil also effectively slowed
the growth of implanted mammary gland cancers [7]. We
hypothesized that a maternal diet that contained canola
oil instead of corn oil would increase maternal dietary
omega 3 PUFA and thus reduce the risk for mammary
gland cancer in the offspring.
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The C3(1) SV40 T-antigen transgenic mouse was
selected as the model for this study. This mouse is a
well characterized model developed in the laboratory of
Dr. Jeffrey E. Green jeffrey.green1@nih.gov. The trans-
gene uses the 5’ flanking region of the rat C3(1) prostate
steroid binding protein to target expression of the SV 40
large T-antigen in the mammary gland and prostate [8].
The female mice develop invasive mammary gland
tumors by 16 weeks of age [8]. The tumors are similar
to human infiltrating ductal carcinomas, are hormone
responsive at early stages but become hormone indepen-
dent in later stages [8] similar to advanced human
breast cancers. The lesions develop in a predictable
time, thus, this mouse is a good model to study altera-
tions in tumorigenesis and progression [8]. The T-anti-
gen is thought to induce cancer by inactivation of p53
[9] and Rb [10], two proteins that are involved in cell
cycle regulation. Both p53 and Rb are tumor suppres-
sors and are frequently mutated in human breast cancer.
Since the mouse has a strong transgenic tumor promo-
ter, complete prevention of tumors would not be
expected but a delay in tumor development or slower
tumor growth compared to a control group would indi-
cate cancer preventive benefit.
Most studies that have tested effects of omega 3 fatty
acids on cancer have used the long chain omega 3 fatty
acids, eicosapentaenoic (EPA, 20 carbons, 5 unsaturations)
or docosahexaenoic (DHA, 22 carbons, 6 unsaturations) as
the test fatty acids [examples: [11-15]. These fatty acids
are most commonly found in fish, thus fish oil or fish oil
concentrates are frequently incorporated into diets. How-
ever, the double bond in the omega 3 position is produced
by plants not by animals, and can be found in plant pro-
ducts as the 18 carbon fat, a-linolenic acid (ALA). Good
dietary sources of ALA include canola oil, walnuts and
‘omega 3 eggs’ [16]. Flaxseed or flaxseed oil is also a good
source of ALA [17] but is often consumed as a dietary
supplement rather than a part of the regular diet. Canola
oil contains about 10% ALA and about 20% linoleic acid
(LA), an 18 carbon omega 6 fatty acid [18], whereas corn
oil contains about 50% LA and about 1% ALA [18]. A
ratio of omega 3 to omega 6 fatty acids of somewhere
between 1:1 and 1:4 has been suggested to be much heal-
thier than the 1:10 to 1:25 ratio of omega 3 to omega 6
fatty acids contained in the usual Western diet [19].
The ALA that is consumed by animals (whether fish,
mouse or human) may be metabolized without change
or it may be elongated and desaturated to longer chain
lipids of the omega 3 series [19]. Humans elongate and
desaturate ALA, however there is controversy about the
efficiency of this conversion [19]. Recent reports indicate
that humans do convert ALA to measurable amounts of
EPA and docosapentaenoic acid (22 carbons, 5 unsa-
turations, omega 3, DPA) and that the conversion is
adequate to reduce measures of inflammation, indicating
biologic activity of the omega 3 fatty acids in humans
[20,21]. Long chain omega 3 PUFA incorporated in tis-
sues have been shown to slow cancer growth in animal
models by multiple mechanisms including: slowing pro-
liferation, increasing apoptosis [22], increasing lipid per-
oxidation [15] and increasing oxidative damage in
cancer cells but not normal cells [15]. Induction of
these mechanisms is correlated with an increased
amount of the n-3 PUFA in the tissues.
Johnson, et. al. used data from the National Health and
Nutrition Survey, 1999-2002, to estimate the actual con-
sumption of ALA and LA in the average American diet
[23]. They report that the usual diet of adult Americans
contains about 14.7 g of LA and about 1.5 g of ALA per
day [23], almost 10 times as much LA as ALA. They esti-
mated that if Americans replaced vegetable oils, butter,
and margarine with canola oil or canola oil based margar-
ine the intakes of ALA would increase to 2.6 g per day and
of LA would decrease to 8.1 g per day [23]. This would
change the ratio of these omega 3 and omega 6 fatty acids
in the diet to about 1:3, a much healthier ratio that would
better meet current dietary fat recommendations [23].
We have shown that the use of canola oil as a source
of omega 3 PUFA significantly slowed the growth rate
of MDA-MB 231 human breast cancers implanted in
nude mice and that the decreased tumor growth rate
was associated with increased long chain omega 3 PUFA
in mouse tissues [7]. There is a suggestion that canola
oil use may be beneficial against cancer in humans in
that women who used canola oil for cooking had a
lower risk for breast cancer than those who used hydro-
genated fats or corn oil [24]. The use of canola oil
instead of corn oil is a diet change that would be easy
to make since canola oil could be substituted for corn
oil in baking, frying and salad dressings. Our results
indicate that such a dietary change could result in
important health benefits, perhaps decreasing risk for
cancer in the next generation.
Methods
Animals
Twenty, female SV129 mice, 6 weeks old were obtained
from Charles River Laboratories (Wilmington, MA).
Breeding pairs of mice bearing a transgene for the SV40
large T antigen with a C3(1) rat prostate steroid binding
protein promoter were obtained from the Dr. Jeffrey
Green. The female transgenic mice are expected to
develop mammary gland cancer due to expression of the
large T antigen in the mammary gland [25]. The trans-
genic line is maintained in the laboratory and all mice are
genotyped to ensure presence of the transgene. All animal
work was approved by the Marshall University School of
Medicine Institutional Animal Care and Use Committee.
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Study design
Mice were quarantined for 2 weeks, and then moved to a
study room. SV129 females were split into 2 groups and
numbered for identification. Ten female mice were placed
on a diet containing 10% w/w corn oil (control diet, see
below) and ten female mice were placed on a diet contain-
ing 10% w/w canola oil (test diet). After 2 weeks these
females were bred with homozygous C3(1)/TAg male
mice. The hemizygous female pups from these breedings
were the experimental mice NOT the wild type mother
mice. Pups were weaned at 21 days old and placed on the
corn oil containing diet, generating two experimental
groups: corn/corn (CO/CO) and canola/corn (CA/CO)
(the first diet is the maternal diet, the second diet is the
pup’s diet). Only the maternal diet of the CA/CO group
contained canola oil not the diet of the experimental pups.
The offspring were housed 3 to 4 in a cage, individually
numbered for identification, and weighed weekly.
Diet
Diets were prepared in the Marshall University School
of Medicine animal diet prep room. Diet composition is
shown in Table 1 and was formulated to be isocaloric,
isonutrient and more relevant to human consumption
than the high fat diets used in many studies. (If a Wes-
tern diet contains about 14.7 g of LA/day [23] the cal-
ories from LA are 6.6% of a 2000 calorie diet. The 10%
corn oil mouse diet contained 10.9% of calories from
LA.) The AIN-76A diet is adequate for the nutritional
support of the mice [26]. The dry ingredients of the
diet, except sugar, were obtained in bulk from MP
Biomedicals (Solon, Ohio), sugar and oil were purchased
locally (100% canola oil or 100% corn oil, no additives
or preservatives). Batches of diet were prepared as
needed, about each two weeks. The diet mixture was
pressed into trays and cut into small squares. Individual
cage sized portions (25-30 g) were stored in sealed con-
tainers at -20°C to prevent oxidation of the fat and bac-
terial growth in the food. Mice had free access to food
and water and were fed fresh food 5 days per week.
Food removed from cages was discarded.
Transgene copy number
Real time PCR was used to verify the presence of the
transgene in all experimental pups. Ear punches (two 2
mm punches, stored at -20°C until processing) were
digested in digestion buffer [50 mM KCl, 1.5 mM
MgCl2, 10 mm Tris pH 8.5, 0.01% Gelatin, 0.45% NP-
40, 0.45% Tween 20 containing 140 mg/ml proteinase K
(Shelton Scientific, Shelton, CN)], followed by dilution
of the samples 1:40 in milliQ water (Milli-Q Advantage,
Millipore, Massachusettes). Primers for the transgene
(SV40 foward: ATA TGC CTT CAT CAG AGG AAT
ATT C; SV40 reverse: TAA AGT TTT AAA CAG AGA
GGA ATC TTT GC) and the VIC labeled SV40PROBE
(VICCCC AGG CAC TCC TTT CAA GAC CTA GAA
GGMGBNFQ) were purchased from Applied Biosystems
(Foster City, CA). Beta-actin primers and FAM labeled
probe (for an internal control) and PCR Master Mix
were also purchased from Applied Biosystems. The
rtPCR assay was performed according to the Applied
Biosystems instructions on an ABI Prism 7000 (Applied
Biosystems, Foster City, CA) instrument.
Tumor growth rates, incidence, multiplicity and weight
Mice were palpated for tumors 3 times weekly from 90
days of age. Lengths and widths of palpable tumors were
measured from the time of detection until euthanasia to
estimate tumor volumes. Tumor volume was estimated
using the formula: (Length × Width × Width)/2. Prism©
software (Graphpad, Inc., La Jolla, CA) was used to plot
tumor growth curves and for regression analyses
to determine the growth rate of each palpable tumor.
A T-test was then used to compare the mean tumor
growth rates between groups of mice.
Total tumor incidence, multiplicity and weights were
determined at necropsy. The differences between groups
and across time were statistically analyzed by two way
analyses of variance, T-test, Fisher exact test or Mann-
Whitney test as appropriate using Prism© software.
Necropsy
Mice were euthanized at 21, 110, 130, 150 and 170 days
of age. Twenty one days of age was the time of weaning.
The earliest time for tumors was expected to be 110
Table 1 Composition of the diets
Ingredient % of wt Amount/100 g Calories/100 g
Casein (protein) 20% 20 g 80
Sucrose 45% 45 g 180
Corn starch
(carbohydrate)
15% 15 g 60
Alphacel (fiber) 5% 5 g 0
Choline bitartrate 0.2% 0.2 g 0
DL-methionine 0.3% 0.3 g 0
Mineral mix 3.5% 3.5 g 0
Vitamin mix 1.0% 1 g 0
Oil (fat) either corn
oil or canola oil
10% 10 g 90
Total 100% 100 g 410
Total fat 90 g 90
Total protein 80 g 80
Total carbohydrate 60 g 240
The AIN-76A was slightly modified to contain 10% w/w corn oil (control diet)
or 10% w/w canola oil (test diet). Control and canola diets were balanced for
calories, nutrients, protein, fat and carbohydrate. The AIN-76A diet is adequate
for growth and nutrition of mice.
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days of age, mice were euthanized each 20 days there-
after to follow the increase in tumor incidence and mul-
tiplicity. The left 4th mammary gland was quickly
removed and frozen in liquid nitrogen. All ten mam-
mary glands were examined for the presence of a tumor
1 mm or larger. All tumors detected were measured,
removed and weighed, thus total tumor weight and
numbers includes many tumors that were too small to
be detected by palpation. If tumor was large enough for
further assay, it was flash frozen in liquid nitrogen. The
number of tumors in each gland and the number of
glands with tumor were recorded for every mouse. Sam-
ples of inguinal fat and liver were removed and frozen
in liquid nitrogen until further analyses.
Body weights
Body weights were measured each week and terminally.
Statistical differences in mean body weight change
between groups were determined using a T-test and
Prism© (Graphpad, Inc) software.
Gas chromatography
The fatty acid compositions of mammary glands and
liver at 3 weeks of age and 130 days of age were ana-
lyzed by gas chromatography. Frozen tissues were
thawed and homogenized in distilled water containing
0.1% BHT to prevent oxidation of the fatty acids. Lipids
were extracted with chloroform/methanol, the fatty
acids were methylated followed by separation and iden-
tification using gas chromatography, as previously
described [7]. Gas chromatography was done using a
PerkinElmer Clarus 500 Gas Chromatograph (Shelton,
CT) with a Elite-5 (5% Diphenyl) Dimethyl-polisiloxane
Series Capillary Column (Length: 30 m, Inner Diameter:
0.25 mm), under the following conditions: initial tem-
perature 150°C, ramp 1 at 175°C for 15 min, ramp 2 at
225°C for 50 min, ramp 3 at 250°C for 10 min, helium
carrier gas flow rate of 1.60 ml/min. Fatty acid methyl
ester standards (Nu-Chek-Prep, Elysian, MN) were used
for peak identification. For a better identification of the
peaks two standards were used: GLC #464 which
contains 52 fatty acids and a custom preparation,
GLC #704, which contains 10 fatty acids, methyl esters
of stearate, oleate, linoleate, alpha linolenate, gamma
linolenate, homogamma linolenate, arachidonate, eicosa-
pentaenoate, docosapentaenoate, and docosahexaenoate.
The fatty acid methyl esters were reported as the per-
cent of the total methylated fatty acids (area under the
curve). Using this protocol and column, we could not
clearly separate the oleic acid (18:1n-9) and alpha linole-
nic acid (ALA 18:3n-3) peaks thus we report these
results as 18:1 + 18:3 ALA. However, the differences in
the peaks due to diet should be mostly ALA since it is
the dietary ALA that was altered. A T-test was used to
determine statistical differences of individual fatty acids
between dietary groups.
Gene expression assay
The Mouse Signal Transduction Pathway Finder™ RT2
Profiler™ PCR Array, PAMM-014 (SuperArray Bioscience
Corporation, Frederick, MD) was used to analyze the
expression of genes in 3-4 mammary glands per group at
130 days of age mice. (The complete list of genes on the
plate can be found at http://www.sabiosciences.com/
rt_pcr_product/HTML/PAMM-014A.html.) Frozen tissue
was homogenized in Tri Reagent (Sigma-Aldrich, St.
Louis, Mo) following the protocol of the manufacturer to
isolate the RNA. RNA quality control was performed for
all samples to insure the purity and integrity of the RNA
on an Agilent 2100 Bioanalyzer (Santa Clara, CA). The
RT2 First Strand Kit was used to make cDNA; the cDNA
was then quantitatively amplified by real time PCR using
an ABI Prism 7000 (Applied Biosystems, Foster City, CA)
and RT2 qPCR Master Mix (Superarray) according to the
manufacturer’s protocol. The protocol and software pro-
vided by SuperArray were followed to determine relative
fold difference in gene expression using the ΔΔct method
and for statistical analyses of the data by T-test.
Immunoblot analysis
Frozen mammary gland tissues were homogenized in
tissue extraction buffer (50 mM Tris, pH 7.4, 250 mM
NaCl, 5 Mm EDTA, 2 mM Na3VO4, 1 mM NaF, 20
mM Na4P2O7, 0.02% NaN3 and proprietary detergent)
from BioSource International, Inc. at 4°C to prepare
cell lysates. Protein concentration was determined by
BCA protein Assay Kit (EMD Biosciences, Inc. Darm-
stadt, Germany) following the manufacturer’s protocol.
Ten micrograms of protein were applied to each lane
of a 4-15% Tris-HCl polyacrylamide gradient gel (Bio-
Rad, Hercules, CA), separated by electrophoresis and
then transferred onto a nitrocellulose membrane. The
blots were blocked with 5% BSA in TBST overnight at
4°C and probed with primary antibodies against
[CCAAT-enhancer binding proteins b (C/EBPb) (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA), fatty acid
synthase (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), glyceraldehyde 3 phosphate dehydrogenase
(GAPDH) (CHEMICON International, Billerica, MA)
or cytokeratin 8 (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA,)] in blocking buffer for 1 hour at room tem-
perature. The membrane was thereafter incubated with
antimouse (Santa Cruz Biotechnology, Inc.) secondary
antibody horseradish peroxidase (HRP) conjugate fol-
lowed by signal detection with chemiluminescence
(ECL Kit, PIERCE, Inc.). Densitometry was used to
quantify bands. A ChemDoc XRS system (Bio-Rad
Laboratories Inc., Hercules, CA) was used to acquire
Ion et al. BMC Cancer 2010, 10:81
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the image then image analysis was done using ‘Quan-
tity One’ software, V. 4.5.2 (Bio-Rad Laboratories Inc.,
Hercules, CA). Data was normalized by cytokeratin
(for size of the epithelial compartment) and by
GAPDH (for protein loading).
Results
Group nomenclature
Groups will be referred to as: 1) CO/CO - mothers fed
the 10% corn oil diet, pup weaned to the 10% corn oil
diet or 2) CA/CO - mothers fed the 10% canola oil diet,
pups weaned to the 10% corn oil diet. Pups were NOT
exposed to the 10% canola oil diet after weaning.
Body weight gain
Mice were allowed free access to food. There was no
difference due to maternal diet in the amount of weight
gained between weaning and 170 days of age by
the groups of experimental mice (p = 0.95 by T-test).
Figure 1 shows the mean amount of weight gained per
mouse per day from weaning until 170 days.
Diet influence on tissue lipid composition
The lipid compositions of the livers and mammary
glands at 21 and 130 days of age are shown in Table 2.
At 21 days of age (the time of weaning), both the
livers and the mammary glands of pups from the CA
mothers contained significantly less (p < 0.05 by T-test)
of the n-6 PUFA (LA and AA) than the livers and mam-
mary glands of pups from the CO mothers.
At 21 days of age, the livers of pups from the CA
mothers contained significantly more (p < 0.05 by
T-test) of the n-3 PUFA, ALA, and significantly more
(p < 0.05 by T-test) of the products of ALA metabolism,
EPA and DHA than the livers of pups from the CO
mothers. The only source of the omega 3 bond was the
ALA in the canola oil. Thus, the ALA in the canola oil
was effectively elongated and desaturated to the longer
chain omega 3 PUFAs, EPA and DHA, for incorporation
into lipids in the liver.
At 21 days of age, the mammary glands of pups from
the CA mothers contained significantly more (p < 0.05
by T-test) ALA and DPA than the pups from the CO
mothers. The content of the longer chain fatty acids:
AA, EPA, DHA and DPA in the mammary glands of
both groups was less that 1% each indicating less incor-
poration of long chain fatty acids or less activity of elon-
gation and desaturation enzymes in the mammary
glands than in the liver.
All mice were fed the corn oil diet from 21 to 130 days
of age. At 130 days of age the livers of the CA/CO group
still contained significantly more (p < 0.05 by T-test) ALA
(n-3 PUFA) and significantly less (p < 0.05 by T-test) AA
(n-6 PUFA) than the CO/CO group. The LA, ALA, and
AA in the mammary glands of the two groups were not
different. EPA, DHA and DPA were almost undetectable
in the mammary glands at 130 days of age, though the
small differences between groups for EPA and DPA were
statistically significant. Both EPA and DHA were signifi-
cantly less (p < 0.05 by T-test) in the mammary glands of
the CA/CO than in the CO/CO group.
Effect of maternal consumption of canola oil instead of
corn oil on tumor multiplicity, incidence and growth
The total number of tumors and the tumor weight per
mouse were assessed in C3(1)TAG/129 female offspring
at 110, 130, 150, 170 days of age. The presence of the
transgene was confirmed in all pups used in the experi-
ment (data not showed).
Incidence
At 110 days of age, no mice had tumors. The tumor
incidence (whether or not a mouse has a tumor) at 130
days of age is shown in Figure 2A. The tumor incidence
of the CA/CO group, (4/17 or 23%) was not quite
Body weight gain/day
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Figure 1 Mean body weight gain between 21 and 130 days of
age. Body weight gain between 21 and 130 days of age was
determined for each mouse. There was no significant difference
between the two groups in body weight gain between weaning
(21 days) and 130 days of age. CO/CO n = 14; CA/CO n = 17 mice,
p = 0.95 by T-test.
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significantly less (p = 0.1) by Fisher’s exact test than the
tumor incidence of the CO/CO group, (7/14 or 50%).
At 150 and 170 days of age, all mice had at least one
tumor, thus the tumor incidence was 100%.
Multiplicity
Since these mice all bear a tumor promoting transgene,
all mice are expected to develop tumors at some point.
As shown in Figure 2B, the tumor multiplicity (number
of tumors per mouse) at 130 days of age was signifi-
cantly less (p < 0.001 by Mann-Whitney) in the CA/CO
group than in the CO/CO group. Even at 170 days of
age, Figure 3A, the multiplicity of tumors in the CA/CO
group was slightly less than in the CO/CO group.
Table 2 Major omega 6 and omega 3 fatty acids in
tissues of mice.
Liver 21 days
Fatty acid Corn oil diet Canola diet p value
18:2 LA 17.35 ± 1.22 12.10 ± 0.90 <0.0001*
18:1+18:3 ALA 9.59 ± 2.16 20.29 ± 2.04 <0.0001*
20:4 AA 18.40 ± 1.60 10.08 ± 0.57 <0.0001*
20:5 EPA 0.09 ± 0.02 1.39 ± 0.20 <0.0001*
22:6 DHA 5.04 ± 0.81 11.22 ± 0.46 <0.0001*
22:5 DPA 0.64 ± 0.08 0.53 ± 0.06 0.023*
Liver 130 days
18:2 LA 23.96 ± 2.74 22.91 ± 0.93 0.5565
18:1+18:3 ALA 18.19 ± 2.47 24.14 ± 1.01 0.0289*
20:4 AA 13.82 ± 0.46 10.33 ± 0.49 0.0041*
20:5 EPA 0.045 ± 0.04 0.10 ± 0.04 0.2382
22:6 DHA 5.37 ± 0.49 3.83 ± 0.17 0.0127*
22:5 DPA 0.315 ± 0.04 0.24 ± 0.03 0.0817
Mammary gland 21 days
18:2 LA 26.25 ± 1.32 6.74 ± 1.99 0.0000*
18:1+18:3 ALA 29.26 ± 0.70 50.99 ± 1.98 0.0000*
20:4 AA 0.67 ± 0.12 0.31 ± 0.11 0.0043*
20:5 EPA 0.06 ± 0.01 0.08 ± 0.05 0.4050
22:6 DHA 0.08 ± 0.02 0.02 ± 0.01 0.0008*
22:5 DPA 0.01 ± 0.01 0.06 ± 0.03 0.0124*
Mammary gland 130 days
18:2 LA 37.15 ± 0.78 35.77 ± 2.30 0.2879
18:1+18:3 ALA 0.40 ± 0.01 0.38 ± 0.03 0.1996
20:4 AA 0.13 ± 0.01 0.11 ± 0.03 0.3218
20:5 EPA 0.02 ± 0.01 0.00 ± 0.00 0.0000*
22:6 DHA 0.01 ± 0.00 0.01 ± 0.01 0.2415
22:5 DPA 0.02 ± 0.00 0.00 ± 0.00 0.0000*
*values in row are significantly different by T-test
The percents of assayed fatty acids of liver and mammary gland at 21 and
130 days old are shown. The results of T-tests between each pair of
treatments for each tissue and time-point are shown, n = 3 to 5 mice per diet
per time point. A p < 0.05 is taken to be statistically significant and is further
indicated by an *
Figure 2 Tumor incidence and multiplicity at 130 days of age.
A. Tumor incidence (fraction of mice with any tumor) at 130 days
of age was not quite significantly different due to the diet of the
mother. CO/CO – 7 of 14 mice had tumors, CA/CO – 4 of 17 mice
had tumors. Fisher’s exact test, p = 0.1. B. Tumor multiplicity, the
mean number of tumors per mouse at 130 days of age. There were
significantly fewer tumors per mouse by Mann-Whitney, p < 0.001.
CO/CO n = 14 mice; CA/CO n = 17 mice. C. The total tumor weight
per mouse was not quite significantly less in the CA/CO group than
in the CO/CO group, p = 0.15 by Mann-Whitney test. CO/CO n = 14
mice; CA/CO n = 17 mice.
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Total tumor weight
The total tumor weight per mouse, calculated from
autopsy data, indicates a difference in tumor burden due
to the diet of the mother during gestation and lactation
of the offspring. At 130 days of age, Figure 2-C, the
tumor weight in the CA/CO group was not quite signifi-
cantly less (p = 0.15 by Mann-Whitney) than that of the
CO/CO group. By 170 days of age, Figure 3-B, the
tumor weight per mouse (due to both fewer tumors/
mouse and slower growth of tumors that developed) in
the CA/CO group was significantly less (p = 0.02 by
Mann-Whitney) than that of the CO/CO group.
Tumor growth rate
The mean tumor growth rates, calculated from
measured tumor growth of 11 tumors for the CO/CO
group and 8 tumors for the CA/CO group, are shown
in Figure 3C. Linear regression analyses were used to
determine the growth rate of each tumor (data
not shown). A T-test of the tumor growth rates
showed that the mean tumor growth rates were slower
in the CA/CO group but not quite significantly
different, p = 0.11.
Number of glands with tumor
The number of glands with tumor at each time point is
illustrated in Figure 4. Two way analysis of variance
revealed that there were significant effects due to both
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Figure 3 Tumor multiplicity at 170 days and growth rate .
A. The mean number of tumors per mouse at 170 days was less,
but not significantly different, in the CA/CO group (n = 11) than in
the CO/CO group (n = 9). B. The tumor weight per mouse at
170 days was significantly less in the CA/CO group (n = 11) than in
the CO/CO group (n = 9), p < 0.02 by Mann-Whitney. C. The mean
tumor growth rate in the CA/CO group from detection until
170 days of age was 1/2 the growth rate of the CO/CO group.
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Figure 4 Glands with tumor per mouse with time. Two way
analyses of variance showed that the number of glands with tumor
per mouse with time was significantly different due to treatment
(p = 0.02) and to time (p = 0.0001). Consumption of the canola oil
containing diet by the mothers of these mice significantly
decreased the number of glands with tumor. As expected, with
time the number of glands with tumor increased in both groups.
Number of mice per group at 110, 130, 150 and 170 days of age
are: CO/CO - 14, 14, 5, 9, and CA/CO – 6, 17, 7, 11 respectively.
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diet and time. The number of glands with tumor was
significantly less in the CA/CO group than in the CO/
CO group, p = 0.02, and as expected, the number of
glands with tumor was significantly increased with time,
p < 0.0001.
Taken together, these data indicate that maternal con-
sumption of canola oil delayed appearance of tumors in
these transgenic mice and slowed the growth rate of the
tumors that arose, resulting in significantly reduced
tumor burden at 170 days of age.
Table 3 Genes expression in mammary glands at 130 days of age.
Gene name Symbol Fold change CA/CO vs CO/CO
Bcl2-associated X protein Bax 22.71
B-cell leukemia/lymphoma 2 Bcl2 4.01
Bcl2-like 1 Bcl2l1 -9.92
Baculoviral IAP repeat-containing 3 Birc3 -2.35
Breast cancer 1 Brca1 -2.35
Chemokine (C-C motif) ligand 2 Ccl2 -2.25
Cyclin-dependent kinase inhibitor 2A Cdkn2a 6.36
CCAAT/enhancer binding protein (C/EBP), beta Cebpb 550.65
Chemokine (C-X-C motif) ligand 9 Cxcl9 2.02
Early growth response 1 Egr1 13.13
Etoposide induced 2.4 mRNA Ei24 -2.15
Engrailed 1 En1 3.48
Fatty acid synthase Fasn -7.09
Fibronectin 1 Fn1 -4.42
Hedgehog-interacting protein Hhip -2.58
Hexokinase 2 Hk2 4.63
Homeo box A1 Hoxa1 -2.07
Intercellular adhesion molecule Icam1 -2.05
Insulin-like growth factor binding protein 3 Igfbp3 -2.51
Inhibitor of kappaB kinase beta Ikbkb -3.13
Interleukin 1 alpha Il1a -2.06
Interleukin 2 receptor, alpha chain Il2ra -3.33
Interleukin 4 receptor, alpha Il4ra -2.19
Lymphoid enhancer binding factor 1 Lef1 -3.02
Lymphotoxin A Lta -3.19
Matrix metallopeptidase 10 Mmp10 2.87
Matrix metallopeptidase 7 Mmp7 2.97
Ngfi-A binding protein 2 Nab2 -4.71
Nitric oxide synthase 2, inducible, macrophage Nos2 -3.31
Patched homolog 1 Ptch1 -3.32
Transcription factor 7, T-cell specific Tcf7 2.53
Telomerase reverse transcriptase Tert -2.55
Transferrin receptor Tfrc -2.04
Transmembrane, prostate androgen induced RNA Tmepai -2.52
Tumor necrosis factor Tnf -5.27
Transformation related protein 53 Trp53 -2.74
Vascular cell adhesion molecule 1 Vcam1 -3.16
Wingless-related MMTV integration site 2 Wnt2 -2.24
Mice were exposed to maternal consumption of either corn or canola oil diets. Real time, reverse transcriptase PCR was performed to determine mRNA
abundance in mammary glands of experimental mice at 130 days of age. Genes with greater than 2 fold differences in mRNA abundance, of the genes analyzed
(see methods), are shown. To better differentiate differences, results of genes with increased expression in the CA/CO group are shifted to the left, results of
genes with decreased expression in the CA/CO group are shifted to the right.
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Effect of maternal diet on gene and protein expression at
130 days of age
Analysis of expression of genes involved in multiple cell
signaling pathways in mammary glands of mice at 130
days of age was used to identify potential mechanisms
for how maternal consumption of canola oil might slow
mammary gland tumorigenesis in C3(1)TAG/129 mice
offspring. We chose this time point since at 130 days of
age there were mammary glands without tumor in each
group so that changes in gene expression due to the
maternal diet but not those due to the presence of a
tumor could be assessed. A priori, we did not know
which signal transduction pathway(s) might be impor-
tant for any alterations in tumor development. The
Mouse Signal Transduction Pathway Finder™ reverse
transcriptase, real time PCR (rtPCR) panel profiles the
expression of 84 key genes representative of 18 different
signal transduction pathways. The CO/CO group was
the control group, the CA/CO group was the experi-
mental group for analysis. The presence of the large
T antigen protein in each mammary gland was con-
firmed by Western Blot (data not shown).
Table 3 presents genes that were analyzed and found
to be at least 2 fold different between the two groups at
130 days of age. Differences in gene expression between
groups at 130 days of age must be due to sustained
gene expression changes induced by the maternal diet
since: 1) both groups were weaned to the same diet 109
days previously and 2) there are only very small differ-
ences in fat composition in the mammary gland at 130
days of age and these differences do not support the
notion that increased n-3 PUFA in the CA/CO group is
influencing gene expression. The possible significances
of some of the changes in gene expression are presented
in the discussion.
The differences in mRNA should be reflected in
changes in protein abundance. Figure 5 illustrates the
results of Western blot for two genes of interest, fatty
acid synthase (Fas) and CCAAT/enhancer binding pro-
tein b (C/EBPb). The mouse mammary gland contains a
high percentage of adipocyte as well as the epithelial
cells that form cancer, thus, the protein change was nor-
malized by the size of the epithelial cell compartment in
the specimen, using cytokeratin, and for protein loading
using GAPDH. Compared to the CO/CO group, at 130
days of age, Fas protein was significantly less in the CA/
CO group whereas C/EBPb protein was increased in the
CA/CO group.
Discussion
The results of this study indicate that incorporation of
canola oil in the maternal diet delayed the development
of mammary gland cancer in this transgenic mouse
model. The mice exposed to canola oil during gestation
and lactation had significantly fewer tumors per mouse
and the tumor incidence was 1/2 that of the control
mice at 130 days of age. By 170 days of age the canola
exposed mice had almost as many tumors as the control
mice. However, since the growth rate of the tumors that
developed in the canola oil exposed mice was about 1/2
that of the control mice and the appearance of tumors
was delayed, the tumor burden (tumor weight) in the
canola exposed mice at 170 days of age was significantly
less than that of the control mice. If these results can be
extrapolated to humans they are important for 2 rea-
sons: 1) incorporation of canola oil in the diet is an easy
dietary change for humans to make and 2) the maternal
diet can have a life-long influence on development of
breast cancer in the daughter.
Epidemiologic studies can be interpreted to support
the notion that the maternal diet can influence breast
cancer risk in the daughter. When Chinese, Japanese or
Filipino women migrate to the United States, breast can-
cer rates rise over two generations to approach that of
US women [27]. Breast cancer incidence in first genera-
tion migrants (who consumed a Western diet but whose
mothers consumed the traditional diet) was increased
almost 3 fold over that of the Asian-born mother, but
Figure 5 Results of protein analyses for fatty acid synthase
(Fas) and CCAAT/enhancer binding protein (C/EBP), beta at
130 days of age. Western blot for fatty acid synthase showed that
Fas protein was significantly less (p = 0.02 by T-test, n = 3/group)
and that C/EBP, b was not quite significantly higher (p = 0.06 by T-
Test, n = 3/group) in mammary glands of CA/CO mice than in CO/
CO mice at 130 days. Values shown are relative density and have
been corrected for protein loading (GAPDH) and for cytokeratin (to
correct for the epithelial compartment of the assayed sample).
Ion et al. BMC Cancer 2010, 10:81
http://www.biomedcentral.com/1471-2407/10/81
Page 9 of 12
was still lower than that of the general Western popula-
tion, indicating that there remained some protection
from breast cancer due to the mother’s traditional diet.
In second generation migrants, whose mothers con-
sumed a Western diet during gestation and lactation of
the daughter, breast cancer risk was 5-fold higher than
the breast cancer risk for the Asian born grandmother
[28] and was the same as the general Western
population.
What could explain the benefit of exposure to mater-
nal consumption of the omega 3 fatty acids in canola
oil? The fatty acid composition of the mammary glands
was different between the two groups at 21 days of age,
but by 130 days of age there were no real differences in
fatty acid composition. However, at 130 days of age,
there were significant differences in gene expression in
the mammary glands of these mice. The PCR array that
we chose assays mRNA abundance in 84 key genes
representative of 18 different signal transduction path-
ways that are important to the development of cancer.
We found that there were multiple differences in gene
expression between the 2 groups of mice when the mice
were 130 days of age, 109 days after the last exposure to
the diet that contained canola oil.
Among the differential changes that were of special
interest was the large increase in CEBPb(CCAAT/
enhancer binding protein b) mRNA. Western blot con-
firmed that the mRNA was being translated to protein
and that the quantity of protein was higher in the CA/
CO group. CEBPb is a leucine zipper transcription fac-
tor. The expression of CEBPb in the liver has been
shown to respond to dietary changes [29]. Homodimers
and heterodimers of CEBPb initiate transcription of
multiple factors involved in proliferation, differentiation
and apoptosis in the mammary gland [30]. Multiple iso-
forms of the protein, (including some that are dominant
negatives) may be generated by truncation or proteolysis
of the CEBPb transcript [31]. Slowed proliferation and
increased differentiation could result in reduced tumor
incidence while promotion of apoptosis could slow
tumor growth. These mechanisms are supported by the
phenotypic data however the exact meaning of increased
CEBPb expression in the mammary gland in this model
will require additional study.
The 7 to 8 fold decrease of fatty acid synthase mRNA
and significant decrease in fatty acid synthase protein by
maternal consumption of the canola oil diet is particu-
larly interesting. Increased expression of fatty acid
synthase has been associated with the early steps of
human mammary carcinogenesis [32]. Conversely, inhi-
bition of fatty acid synthase has been associated with
apoptosis of human breast cancer cells [33] and has
been suggested as a target for chemoprevention of
breast cancer [34]. In cell culture studies, a-linolenic
acid (increased in the canola oil diet) has been shown to
be tumoricidal to breast cancer cells and to inhibit the
overexpression of fatty acid synthase [35]. The long
term suppression of fatty acid synthase would contribute
to reduced tumor burden seen in this model.
Another gene expression change that could reduce
tumor burden was the 13 fold increased expression of
Egr1 mRNA in the CA/CO group. Egr1 is a tumor sup-
pressor gene that has been associated with suppression
of proliferation [36]. The expression of this gene has
been shown to be increased by genistein and by reti-
noids [36,37] providing precedent for the regulation of
this gene by dietary components.
Even though we did not directly assess NFB activa-
tion, the mRNA results suggest that activation of the
transcription factor NFB was reduced in mammary
glands of pups from mothers that consumed the canola
oil diet. The mRNA for inhibitor of B kinase b (IKKb)
was reduced 3 fold in CA/CO pups at 130 days of age.
Activation of IKKb results in the phosphorylation of IB
(inhibitor of B) and allows formation of NFB dimers
that can translocate to the nucleus and activate tran-
scription of downstream genes [38]. Activation of IKKb
is an important regulatory step in NFB activity [38],
thus reduced IKKb would be expected to result in
decreased activation of NFB and reduction in mRNA
of genes that are transcribed following NFB binding.
Genes downstream from NFB include inducible nitric
oxide synthase (iNOS), tumor necrosis factor (TNF) and
vascular cell adhesion molecule 1 (Vcam1). The mRNA
from each of these genes was decreased 2 to 5 fold, sup-
porting the idea that NFB activation was reduced in
the CA/CO pups. Clearly there is much work to be
done to verify this notion and to identify mechanisms.
The mRNA changes in the Bcl-2 apoptotic pathway
were also intriguing. Progression to apoptosis is a bal-
ance between pro-apoptotic genes such as Bcl-2 asso-
ciated X (BAX) and anti-apoptotic genes such as Bcl-2
and Bcl-2-like-1 [39]. At 130 days of age, the mammary
glands of CA/CO mice had BAX mRNA at 22 fold and
BCL-2-like 1 at -10 fold that of the CO/CO mice. Bcl2
was increased 4 fold but clearly the overall balance is to
promotion of apoptosis of defective epithelial cells in
the CA/CO mammary glands.
Conclusions
Clearly consumption of canola oil by mothers of the
experimental mice delayed mammary gland tumor
development in this model. Our gene expression data
have provided clues to mechanisms employed but iden-
tifying and verifying the mechanism(s) remains to be
done. Since long term changes in the expression of mul-
tiple proteins, such as seen in this study, are often
related to epigenetic modification of the promoter
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region of genes, we have initiated epigenetic studies to
identify these changes. Future work includes verification
of protein changes and developing reasonable pathways
for the delay in cancer development seen in this model.
It has been suggested that 30% or more of cancers
could be prevented by dietary changes [40]. Substituting
canola oil for corn oil would increase the ratio of omega
3 fatty acids in the diet and is an easy, cost effective
dietary change for people to make. Many animal studies
have shown that increasing omega 3 fatty acids in the
adult diet provides multiple benefits against cancer. This
work suggests that substituting canola oil for the corn
oil in the maternal diet may decrease risk for breast can-
cer in the daughter in addition to providing benefit for
the mother.
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